168 related articles for article (PubMed ID: 16607923)
1. Effects of growth hormone (GH) and insulin-like growth factor-I therapy in patients with gene defects in the GH axis.
Riedl S; Frisch H
J Pediatr Endocrinol Metab; 2006 Mar; 19(3):229-36. PubMed ID: 16607923
[TBL] [Abstract][Full Text] [Related]
2. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature.
Goddard AD; Dowd P; Chernausek S; Geffner M; Gertner J; Hintz R; Hopwood N; Kaplan S; Plotnick L; Rogol A; Rosenfield R; Saenger P; Mauras N; Hershkopf R; Angulo M; Attie K
J Pediatr; 1997 Jul; 131(1 Pt 2):S51-5. PubMed ID: 9255229
[TBL] [Abstract][Full Text] [Related]
3. Long-term auxological and pubertal outcome of patients with hereditary insulin-like growth factor-I deficiency (Laron and growth hormone-gene deletion syndrome) treated with recombinant human insulin-like growth factor-I.
Messina MF; Arrigo T; Valenzise M; Ghizzoni L; Caruso-Nicoletti M; Zucchini S; Chiabotto P; Crisafulli G; Zirilli G; De Luca F
J Endocrinol Invest; 2011 Apr; 34(4):292-5. PubMed ID: 20543555
[TBL] [Abstract][Full Text] [Related]
4. Effects of insulin-like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome. GHIS Collaborative Group.
Underwood LE; Backeljauw P; Duncan V
Acta Paediatr Suppl; 1999 Feb; 88(428):182-4. PubMed ID: 10102077
[TBL] [Abstract][Full Text] [Related]
5. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
7. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
Attie KM; Julius JR; Stoppani C; Rundle AC
J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I treatment in two children with growth hormone gene deletions.
Arnhold IJ; Oliveira SB; Osorio MG; Mendonca BB
J Pediatr Endocrinol Metab; 1999; 12(4):499-506. PubMed ID: 10417965
[TBL] [Abstract][Full Text] [Related]
9. Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I.
Besson A; Salemi S; Eblé A; Joncourt F; Gallati S; Jorge AA; Mullis PE
Eur J Endocrinol; 2004 May; 150(5):635-42. PubMed ID: 15132718
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
Kemp SF
BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
[TBL] [Abstract][Full Text] [Related]
12. GH deficiency status combined with GH receptor polymorphism affects response to GH in children.
Valsesia A; Chatelain P; Stevens A; Peterkova VA; Belgorosky A; Maghnie M; Antoniazzi F; Koledova E; Wojcik J; Farmer P; Destenaves B; Clayton P;
Eur J Endocrinol; 2015 Dec; 173(6):777-89. PubMed ID: 26340968
[TBL] [Abstract][Full Text] [Related]
13. Laron syndrome: clinical features, molecular pathology and treatment.
Laron Z; Klinger B
Horm Res; 1994; 42(4-5):198-202. PubMed ID: 7868073
[TBL] [Abstract][Full Text] [Related]
14. Genetics of GHRH, GHRH-receptor, GH and GH-receptor: its impact on pharmacogenetics.
Mullis PE
Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):25-41. PubMed ID: 21396573
[TBL] [Abstract][Full Text] [Related]
15. Recombinant IGF-I: Past, present and future.
Bright GM
Growth Horm IGF Res; 2016 Jun; 28():62-5. PubMed ID: 26822565
[TBL] [Abstract][Full Text] [Related]
16. Isolated Growth Hormone Deficiency Type 2 due to a novel
Kautsar A; Wit JM; Pulungan A
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):426-431. PubMed ID: 30678423
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation.
Chatterjee S; Shapiro L; Rose SJ; Mushtaq T; Clayton PE; Ten SB; Bhangoo A; Kumbattae U; Dias R; Savage MO; Metherell LA; Storr HL
Eur J Endocrinol; 2018 May; 178(5):481-489. PubMed ID: 29500309
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I treatment in primary growth hormone insensitivity: effect of recombinant human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-binding protein-3 complex.
Tonella P; Flück CE; Mullis PE
Horm Res Paediatr; 2010; 73(2):140-7. PubMed ID: 20190552
[TBL] [Abstract][Full Text] [Related]
20. [Growth Hormone-Insulin Growth Factor I (GH-IGF-I) axis and growth].
Castell AL; Sadoul JL; Bouvattier C
Ann Endocrinol (Paris); 2013 Oct; 74 Suppl 1():S33-41. PubMed ID: 24356290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
